SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Leonard Bielory, Brett P Bielory, Rudolph S Wagner, Pediatric Allergy: Principles and Practice, 2016,

    CrossRef

  2. 2
    Kotaro Hiraoka, Manabu Tashiro, Thomas Grobosch, Marcus Maurer, Keiichi Oda, Jun Toyohara, Kenji Ishii, Kiichi Ishiwata, Kazuhiko Yanai, Brain histamine H1receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine, Expert Opinion on Drug Safety, 2015, 14, 2, 199

    CrossRef

  3. 3
    Kimihiro Okubo, Masahiko Ichimura, Tomoya Koyama, Yutaka Susuta, Hitoshi Izaki, Double-blind placebo-controlled study of bepotastine besilate in pediatric patients with perennial allergic rhinitis, Expert Opinion on Pharmacotherapy, 2015, 16, 16, 2395

    CrossRef

  4. 4
    Yawen Hu, Deidra E. Sieck, Walter H. Hsu, Why are second-generation H1-antihistamines minimally sedating?, European Journal of Pharmacology, 2015, 765, 100

    CrossRef

  5. 5
    Magí Farré, Clara Pérez-Mañá, Esther Papaseit, Esther Menoyo, Marta Pérez, Soraya Martin, Santiago Bullich, Santiago Rojas, José-Raúl Herance, Carlos Trampal, Luis Labeaga, Román Valiente, Bilastine vs. hydroxyzine: occupation of brain histamine H1-receptors evaluated by positron emission tomography in healthy volunteers, British Journal of Clinical Pharmacology, 2014, 78, 5
  6. 6
    Jianzhong Shentu, Huili Zhou, Xingjiang Hu, Guolan Wu, Lihua Wu, Meixiang Zhu, You Zhai, Yunliang Zheng, Jian Liu, Comparative Fasting Bioavailability of 2 Bepotastine Formulations in Healthy Male Chinese Volunteers: An Open-Label, Randomized, Single-Dose, 2-Way Crossover Study, Clinical Therapeutics, 2014, 36, 4, 579

    CrossRef

  7. 7
    Y. K. Choi, Y. H. Chung, Y. S. Nam, D. Y. Kang, H. Kim, S. E. Lee, H. R. Kim, Y. S. Lee, J. H. Jeong, UPLC-MS/MS Method for Determination of Bepotastine in Human Plasma, Journal of Chromatographic Science, 2014, 52, 8, 886

    CrossRef

  8. 8
    Uta Funke, Danielle J. Vugts, Bieneke Janssen, Arnold Spaans, Perry S. Kruijer, Adriaan A. Lammertsma, Lars R. Perk, Albert D. Windhorst, 11C-labeled and 18F-labeled PET ligands for subtype-specific imaging of histamine receptors in the brain, Journal of Labelled Compounds and Radiopharmaceuticals, 2013, 56, 3-4
  9. 9
    Leonard Bielory, Shubhasree Duttachoudhury, Andrea McMunn, Bepotastine besilate for the treatment of pruritus, Expert Opinion on Pharmacotherapy, 2013, 14, 18, 2553

    CrossRef

  10. 10
    Hirotoshi Sato, Chihiro Ito, Manabu Tashiro, Kotaro Hiraoka, Katsuhiko Shibuya, Yoshihito Funaki, Ren Iwata, Hiroo Matsuoka, Kazuhiko Yanai, Histamine H1 receptor occupancy by the new-generation antidepressants fluvoxamine and mirtazapine: a positron emission tomography study in healthy volunteers, Psychopharmacology, 2013, 230, 2, 227

    CrossRef

  11. 11
    Silke Conen, Eef L. Theunissen, Annemiek Vermeeren, Peter van Ruitenbeek, Peter Stiers, Mitul A. Mehta, Stefan W. Toennes, Johannes G. Ramaekers, The role of P-glycoprotein in CNS antihistamine effects, Psychopharmacology, 2013, 229, 1, 9

    CrossRef

  12. 12
    Patrick T. Udvardi, Ester Nespoli, Francesca Rizzo, Bastian Hengerer, Andrea G. Ludolph, Advances in the Neurochemistry and Neuropharmacology of Tourette Syndrome, 2013,

    CrossRef

  13. 13
    Yasuko Katayose, Sayaka Aritake, Shingo Kitamura, Minori Enomoto, Akiko Hida, Kiyohisa Takahashi, Kazuo Mishima, Carryover effect on next-day sleepiness and psychomotor performance of nighttime administered antihistaminic drugs: a randomized controlled trial, Human Psychopharmacology: Clinical and Experimental, 2012, 27, 4
  14. 14
    Hancheng Cai, Thomas J. Mangner, Otto Muzik, Xin Lu, Pulak K. Chakraborty, Diane C. Chugani, Harry T. Chugani, Fully Automated Production of 11C-Doxepin for PET Imaging Histamine H1 Receptor, Molecular Imaging and Biology, 2012, 14, 5, 546

    CrossRef

  15. 15
    Nobuo Kubo, Michio Senda, Yasunori Ohsumi, Setsu Sakamoto, Keiichi Matsumoto, Manabu Tashiro, Nobuyuki Okamura, Kazuhiko Yanai, Brain histamine H1 receptor occupancy of loratadine measured by positron emission topography: comparison of H1 receptor occupancy and proportional impairment ratio, Human Psychopharmacology: Clinical and Experimental, 2011, 26, 2
  16. 16
    F. Estelle R. Simons, Keith J. Simons, Histamine and H1-antihistamines: Celebrating a century of progress, Journal of Allergy and Clinical Immunology, 2011, 128, 6, 1139

    CrossRef

  17. 17
    Yuichi Sugiyama, Shinji Yamashita, Impact of microdosing clinical study — Why necessary and how useful?, Advanced Drug Delivery Reviews, 2011, 63, 7, 494

    CrossRef

  18. 18
    Mizuki SAWADA, Reiko SUZAKI, Sumiko ISHIZAKI, Masaru TANAKA, Influence of 'Prior Explanation Concerning Taste by Doctor' to Patient Compliance of Bepotastine Besilate OD Tablets, Nishi Nihon Hifuka, 2011, 73, 4, 402

    CrossRef

  19. 19
    Kazuhiko Yanai, Dongying Zhang, Manabu Tashiro, Takeo Yoshikawa, Fumito Naganuma, Ryuichi Harada, Tadaho Nakamura, Katsuhiko Shibuya, Nobuyuki Okamura, Positron emission tomography evaluation of sedative properties of antihistamines, Expert Opinion on Drug Safety, 2011, 10, 4, 613

    CrossRef

  20. 20
    Silke Conen, Eef L. Theunissen, Annemiek Vermeeren, Johannes G. Ramaekers, Short-Term Effects of Morning Versus Evening Dose of Hydroxyzine 50 mg on Cognition in Healthy Volunteers, Journal of Clinical Psychopharmacology, 2011, 31, 3, 294

    CrossRef

  21. 21
    Manabu TASHIRO, Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 2011, 42, 4, 245

    CrossRef

  22. 22
    Andrew D. Krystal, Principles and Practice of Sleep Medicine, 2011,

    CrossRef

  23. 23
    Mutsumi OMORI, Satoshi TAKEUCHI, Akari TASHIRO, Takeshi NAKAHARA, Chikage MITOMA, Hiroshi TERAO, Yasushi URATA, Eri YOSHIMURA, Kyoko KUDO, Shinsuke YASUKAWA, Jun TSUJITA, Hisashi KOKUBA, Kana MASUNAGA, Kentaro KUWAHARA, Ryutaro ICHIKAWA, Eriko ITO, Hiromichi TAKESHITA, Fumiko YASUKAWA, Atsuko NISHIE, Yoichi MOROI, Masutaka FURUE, A Questionnaire-based Survey on the Clinical Efficacy of Bepotastine Besilate in the Treatment of Patients with Pruritic Skin Diseases, Nishi Nihon Hifuka, 2010, 72, 3, 240

    CrossRef

  24. 24
    Dongying Zhang, Manabu Tashiro, Katsuhiko Shibuya, Nobuyuki Okamura, Yoshihito Funaki, Takeo Yoshikawa, Masato Kato, Kazuhiko Yanai, Next-Day Residual Sedative Effect After Nighttime Administration of an Over-the-Counter Antihistamine Sleep Aid, Diphenhydramine, Measured by Positron Emission Tomography, Journal of Clinical Psychopharmacology, 2010, 30, 6, 694

    CrossRef

  25. 25
    Katherine A. Lyseng-Williamson, Oral Bepotastine, Drugs, 2010, 70, 12, 1579

    CrossRef

  26. You have free access to this content26
    M. K. Church, M. Maurer, F. E. R. Simons, C. Bindslev-Jensen, P. Van Cauwenberge, J. Bousquet, S. T. Holgate, T. Zuberbier, Risk of first-generation H1-antihistamines: a GA2LEN position paper, Allergy, 2010, 65, 4
  27. 27
    Kazuhiro Hashiguchi, Huaipeng Tang, Toshio Fujita, Kiyochika Suematsu, Minoru Gotoh, Kimihiro Okubo, Bepotastine besilate OD tablets suppress nasal symptoms caused by Japanese cedar pollen exposure in an artificial exposure chamber (OHIO Chamber), Expert Opinion on Pharmacotherapy, 2009, 10, 4, 523

    CrossRef

  28. 28
    Mikako Ogawa, Hideo Tsukada, Kentaro Hatano, Yasuomi Ouchi, Hideo Saji, Yasuhiro Magata, Central in Vivo Nicotinic Acetylcholine Receptor Imaging Agents for Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT), Biological & Pharmaceutical Bulletin, 2009, 32, 3, 337

    CrossRef

  29. 29
    Manabu Tashiro, Motohisa Kato, Masayasu Miyake, Shoichi Watanuki, Yoshihito Funaki, Yoichi Ishikawa, Ren Iwata, Kazuhiko Yanai, Dose dependency of brain histamine H1 receptor occupancy following oral administration of cetirizine hydrochloride measured using PET with [11C]doxepin, Human Psychopharmacology: Clinical and Experimental, 2009, 24, 7
  30. 30
    Martin K. Church, Michel Gillard, Maria Laura Sargentini-Maier, Italo Poggesi, Alison Campbell, Margherita Strolin Benedetti, From pharmacokinetics to therapeutics, Drug Metabolism Reviews, 2009, 41, 3, 455

    CrossRef

  31. 31
    Harold W Goforth, Low-dose doxepin for the treatment of insomnia: emerging data, Expert Opinion on Pharmacotherapy, 2009, 10, 10, 1649

    CrossRef

  32. 32
    Mark B. Abelson, Gail L. Torkildsen, Jon I. Williams, James A. Gow, Paul J. Gomes, Timothy R. McNamara, Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: A phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children, Clinical Therapeutics, 2009, 31, 9, 1908

    CrossRef

  33. 33
    J. M. Ritter, Drug regulation & therapeutic efficacy, British Journal of Clinical Pharmacology, 2008, 65, 6
  34. 34
    Stephen M. Moerlein, Zhude Tu, PET IMAGING OF THE PHARMACOKINETICS OF SMALL MOLECULAR-WEIGHT DRUGS,